Healthmaxx Recalls MAX Kidney Strong Tablets Due to Mislabeling
Healthmaxx Global Inc. is voluntarily recalling MAX Brand Kidney Strong tablets because the label does not match the actual product or ingredients.
The agency’s classification
FDA (Food): Class III
Class III is a situation in which use of or exposure to a violative product is not likely to cause adverse health consequences.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 2/5 (Moderate).
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class III, which the rubric defines as typically scoring 1 or 2 because it is unlikely to cause adverse health consequences. The specific hazard is mislabeling, which aligns with the 'Moderate' criteria for labeling errors.
Plain-English summary
Healthmaxx Global Inc. is voluntarily recalling 1,972 bottles of MAX Brand Kidney Strong, 120 Count Tablets. The recall was initiated in response to a U.S. Food and Drug Administration (FDA) inspection that identified mislabeling issues. The product was distributed in California, Maryland, and New York.
The FDA determined that the product named on the label is not the actual product contained in the bottle, and the ingredients listed on the label are not the actual ingredients contained. The specific lot number for the recalled product is T2K002, and the UPC is 6 65176 13427 2.
Consumers who have purchased this product should stop using it and contact Healthmaxx Global Inc. for a refund or further instructions. The FDA classifies this as a Class III recall, indicating that the mislabeling is unlikely to cause adverse health consequences.
The recalled product
- Product
- MAX Brand Kidney Strong, 120 Count Tablets Product labeling reads in part:"MAX KIDNEY STRONG***Dietary Supplement 120 Tablets***6 65176 13427 2***Manufactured for: HealthMax Products, Inc. Altadena, CA 91001***".
- Manufacturer
- Healthmaxx Global Inc.
- Category
- Food — Dietary Supplement
- Hazard
- Affected units
- 1,972
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- Lot # T2K002 UPC 6 65176 13427 2
Distribution
Part of a larger recall action
This product is one of 28 recalled by Healthmaxx Global Inc. under a single FDA (Food) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 28 products in this recall →Related recalls
Same manufacturer · Healthmaxx Global Inc.
See all →- ModerateHealthmaxx Recalls Organic Grapeseed Extract Due to Mislabeling
FDA (Food) · 2013-10-02
- ModerateHealthmaxx Recalls MAX Organic Blueberry Capsules for Mislabeling
FDA (Food) · 2013-10-02
- ModerateHealthmaxx Recalls Stem Cell Enhance Supplements Due to Mislabeling
FDA (Food) · 2013-10-02
- LowHealthmaxx Global Recalls MAX Nitric Oxide Enhance Due to Mislabeling
FDA (Food) · 2013-10-02
- ModerateHealthmaxx Global Recalls Max Blood Sugar Defense Due to Mislabeling
FDA (Food) · 2013-10-02
Same hazard · mis labeling
See all →- SevereWhite Vein Advanced Alkaloids Chewable Tablets Recall for Excess Active Ingredient
FDA (Food) · 2026-10-14
- SevereBetter Bakehouse Recalls Donutful Chocolate Dipped Vanilla Cake Donuts for Undeclared Milk
FDA (Food) · 2026-10-14
- HighFreshPoint Recalls Cranberry Chicken Salad Wedges for Undeclared Egg Allergen
FDA (Food) · 2026-10-14
- HighJ K Patisserie & Bakery LLC Recalls Croissants for Undeclared Egg
FDA (Food) · 2026-10-14
- ModerateHalyard Laparoscopy Comprehensive Pack II Recalled for Latex Content
FDA (Devices) · 2026-10-14
Similar recalls
- ModerateFDA Recalls Fexofenadine Tablets Due to Potential Labeling Error
FDA (Drugs) · 2014-01-22
- SevereFDA Recalls Fexofenadine Tablets Due to Potential Labeling Mixup
FDA (Drugs) · 2014-01-22
- ModerateHerbal Doctor Remedies Recalls Max Slim Capsules for Misbranding
FDA (Drugs) · 2020-04-15
- ModerateAidapak Recalls OXcarbazepine Tablets Due to Potential Labeling Error
FDA (Drugs) · 2014-01-22
- LowCalci-Max Dietary Supplement Recalled for Zinc Content Deficiency
FDA (Food) · 2020-05-06
- SevereFDA Recalls Tizanidine Tablets Due to Potential Labeling Error
FDA (Drugs) · 2014-01-22